https://bit.ly/3FpzE4s

NEIAA measures the quality of care delivered to patients in England and Wales with suspected and newly diagnosed early inflammatory arthritis (EIA). Quality of care is measured against the best practice guidelines set out by NICE quality standard 33 (QS33). This is the fifth NEIAA annual report and the first State of the Nation report for the programme, presenting data on five key metrics of care: time to referral, time to assessment, time to treatment, response to treatment and patient-reported outcome measures (PROMs).NEIAA 旨在评估英格兰及威尔士地区疑似或新确诊早期炎性关节炎（early inflammatory arthritis，EIA）患者的诊疗服务质量。其诊疗质量评估遵循英国国家卫生与临床优化研究所（NICE）第33项质量标准（QS33）所明确的最佳实践指南。本报告为NEIAA的第五份年度报告，亦是该项目的首份全国现状报告，呈现了五项核心诊疗质量指标的相关数据：转诊时限、评估时限、治疗时限、治疗应答效果以及患者报告结局指标（patient-reported outcome measures，PROMs）。